0 XP   0   0   0

Novo Nordisk A/S










Financial Health of Novo Nordisk A/S




Comparing to competitors in the Other industry




  Industry Rankings  


Richest
#39 / 452

Total Sales
#29 / 452

Making Money
#13 / 452

Working Efficiently
#34 / 452

Novo Nordisk A/S
Buy, Hold or Sell?

Should you buy, hold or sell Novo Nordisk A/S?

I guess you are interested in Novo Nordisk A/S. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Novo Nordisk A/S

Let's start. I'm going to help you getting a better view of Novo Nordisk A/S. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Novo Nordisk A/S even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Novo Nordisk A/S is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Novo Nordisk A/S. The closing price on 2022-12-01 was €120.02 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Novo Nordisk A/S Daily Candlestick Chart

Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

1.1. Profitability of Novo Nordisk A/S.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Novo Nordisk A/S earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Novo Nordisk A/S to the Other industry mean.
  • A Net Profit Margin of 32.3% means that €0.32 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Novo Nordisk A/S:

  • The MRQ is 32.3%. The company is making a huge profit. +2
  • The TTM is 32.1%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ32.3%TTM32.1%+0.1%
TTM32.1%YOY34.1%-2.0%
TTM32.1%5Y33.1%-1.0%
5Y33.1%10Y33.1%0.0%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ32.3%8.2%+24.1%
TTM32.1%7.4%+24.7%
YOY34.1%7.3%+26.8%
5Y33.1%6.7%+26.4%
10Y33.1%6.6%+26.5%
1.1.2. Return on Assets

Shows how efficient Novo Nordisk A/S is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Novo Nordisk A/S to the Other industry mean.
  • 6.1% Return on Assets means that Novo Nordisk A/S generated €0.06 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Novo Nordisk A/S:

  • The MRQ is 6.1%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 6.5%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ6.1%TTM6.5%-0.4%
TTM6.5%YOY7.6%-1.1%
TTM6.5%5Y7.6%-1.1%
5Y7.6%10Y7.6%0.0%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ6.1%1.0%+5.1%
TTM6.5%1.0%+5.5%
YOY7.6%0.9%+6.7%
5Y7.6%0.9%+6.7%
10Y7.6%0.9%+6.7%
1.1.3. Return on Equity

Shows how efficient Novo Nordisk A/S is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Novo Nordisk A/S to the Other industry mean.
  • 17.9% Return on Equity means Novo Nordisk A/S generated €0.18 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Novo Nordisk A/S:

  • The MRQ is 17.9%. Using its investors money, the company is efficient in making profit. +1
  • The TTM is 18.2%. Using its investors money, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ17.9%TTM18.2%-0.4%
TTM18.2%YOY18.0%+0.2%
TTM18.2%5Y18.5%-0.3%
5Y18.5%10Y18.5%0.0%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ17.9%3.1%+14.8%
TTM18.2%2.9%+15.3%
YOY18.0%2.6%+15.4%
5Y18.5%2.4%+16.1%
10Y18.5%2.4%+16.1%

1.2. Operating Efficiency of Novo Nordisk A/S.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Novo Nordisk A/S is operating .

  • Measures how much profit Novo Nordisk A/S makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Novo Nordisk A/S to the Other industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Novo Nordisk A/S:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY21.3%-21.3%
TTM-5Y26.2%-26.2%
5Y26.2%10Y26.2%0.0%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ-17.1%-17.1%
TTM-9.1%-9.1%
YOY21.3%9.2%+12.1%
5Y26.2%8.5%+17.7%
10Y26.2%8.5%+17.7%
1.2.2. Operating Ratio

Measures how efficient Novo Nordisk A/S is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Other industry mean).
  • An Operation Ratio of 0.70 means that the operating costs are €0.70 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Novo Nordisk A/S:

  • The MRQ is 0.701. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.740. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ0.701TTM0.740-0.038
TTM0.740YOY0.757-0.017
TTM0.7405Y0.735+0.005
5Y0.73510Y0.7350.000
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7011.218-0.517
TTM0.7401.189-0.449
YOY0.7571.203-0.446
5Y0.7351.289-0.554
10Y0.7351.314-0.579

1.3. Liquidity of Novo Nordisk A/S.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Novo Nordisk A/S is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Other industry mean).
  • A Current Ratio of 0.94 means the company has €0.94 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Novo Nordisk A/S:

  • The MRQ is 0.939. The company is just not able to pay all its short-term debts. -1
  • The TTM is 0.934. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ0.939TTM0.934+0.005
TTM0.934YOY0.971-0.036
TTM0.9345Y0.984-0.050
5Y0.98410Y0.9840.000
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9391.491-0.552
TTM0.9341.465-0.531
YOY0.9711.475-0.504
5Y0.9841.299-0.315
10Y0.9841.286-0.302
1.3.2. Quick Ratio

Measures if Novo Nordisk A/S is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Novo Nordisk A/S to the Other industry mean.
  • A Quick Ratio of 0.45 means the company can pay off €0.45 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Novo Nordisk A/S:

  • The MRQ is 0.448. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.445. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.448TTM0.445+0.003
TTM0.445YOY0.388+0.057
TTM0.4455Y0.412+0.032
5Y0.41210Y0.4120.000
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4480.612-0.164
TTM0.4450.602-0.157
YOY0.3880.600-0.212
5Y0.4120.563-0.151
10Y0.4120.552-0.140

1.4. Solvency of Novo Nordisk A/S.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Novo Nordisk A/S assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Novo Nordisk A/S to Other industry mean.
  • A Debt to Asset Ratio of 0.66 means that Novo Nordisk A/S assets are financed with 66.0% credit (debt) and the remaining percentage (100% - 66.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Novo Nordisk A/S:

  • The MRQ is 0.660. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.645. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.660TTM0.645+0.015
TTM0.645YOY0.577+0.067
TTM0.6455Y0.590+0.055
5Y0.59010Y0.5900.000
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6600.562+0.098
TTM0.6450.583+0.062
YOY0.5770.586-0.009
5Y0.5900.583+0.007
10Y0.5900.576+0.014
1.4.2. Debt to Equity Ratio

Measures if Novo Nordisk A/S is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Novo Nordisk A/S to the Other industry mean.
  • A Debt to Equity ratio of 194.1% means that company has €1.94 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Novo Nordisk A/S:

  • The MRQ is 1.941. The company is just able to pay all its debts with equity.
  • The TTM is 1.821. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ1.941TTM1.821+0.119
TTM1.821YOY1.367+0.455
TTM1.8215Y1.459+0.362
5Y1.45910Y1.4590.000
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ1.9411.244+0.697
TTM1.8211.337+0.484
YOY1.3671.370-0.003
5Y1.4591.439+0.020
10Y1.4591.455+0.004

2. Market Valuation of Novo Nordisk A/S

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Novo Nordisk A/S generates.

  • Above 15 is considered overpriced but always compare Novo Nordisk A/S to the Other industry mean.
  • A PE ratio of 133.84 means the investor is paying €133.84 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Novo Nordisk A/S:

  • The EOD is 151.943. Seems overpriced? -1
  • The MRQ is 133.840. Seems overpriced? -1
  • The TTM is 131.628. Seems overpriced? -1
Trends
Current periodCompared to+/- 
EOD151.943MRQ133.840+18.104
MRQ133.840TTM131.628+2.212
TTM131.628YOY96.629+34.999
TTM131.6285Y85.334+46.294
5Y85.33410Y85.3340.000
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD151.94336.308+115.635
MRQ133.84038.458+95.382
TTM131.62844.588+87.040
YOY96.62948.072+48.557
5Y85.33440.090+45.244
10Y85.33441.443+43.891
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Novo Nordisk A/S.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of Novo Nordisk A/S:

  • The MRQ is -2,138.984. Very Bad. -2
  • The TTM is 12,849.270. Seems overpriced? -1
Trends
Current periodCompared to+/- 
MRQ-2,138.984TTM12,849.270-14,988.254
TTM12,849.270YOY-1,733.013+14,582.283
TTM12,849.2705Y4,002.543+8,846.727
5Y4,002.54310Y4,002.5430.000
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ-2,138.9840.154-2,139.138
TTM12,849.2700.050+12,849.220
YOY-1,733.0130.186-1,733.199
5Y4,002.5430.158+4,002.385
10Y4,002.5430.155+4,002.388

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Novo Nordisk A/S is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Other industry mean).
  • A PB ratio of 23.94 means the investor is paying €23.94 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Novo Nordisk A/S:

  • The EOD is 27.180. Seems overpriced? -1
  • The MRQ is 23.941. Seems overpriced? -1
  • The TTM is 23.741. Seems overpriced? -1
Trends
Current periodCompared to+/- 
EOD27.180MRQ23.941+3.238
MRQ23.941TTM23.741+0.200
TTM23.741YOY17.146+6.595
TTM23.7415Y15.286+8.455
5Y15.28610Y15.2860.000
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD27.1801.411+25.769
MRQ23.9411.419+22.522
TTM23.7411.575+22.166
YOY17.1461.352+15.794
5Y15.2861.288+13.998
10Y15.2861.330+13.956
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Novo Nordisk A/S compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.4850.145+235%0.095+411%0.401+21%0.401+21%
Book Value Growth--0.059-0.022+137%-0.032+155%-0.019+132%-0.019+132%
Book Value Per Share--4.4164.085+8%3.575+24%2.888+53%2.888+53%
Book Value Per Share Growth--0.1100.033+235%0.024+367%0.117-6%0.117-6%
Current Ratio--0.9390.934+1%0.971-3%0.984-5%0.984-5%
Debt To Asset Ratio--0.6600.645+2%0.577+14%0.590+12%0.590+12%
Debt To Equity Ratio--1.9411.821+7%1.367+42%1.459+33%1.459+33%
Dividend Per Share---0.349-100%0.306-100%0.304-100%0.304-100%
Eps--0.7900.743+6%0.643+23%0.523+51%0.523+51%
Eps Growth---0.0630.016-502%0.024-366%0.121-152%0.121-152%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Net Profit Margin--0.3230.321+0%0.341-5%0.331-3%0.331-3%
Operating Margin----0%0.213-100%0.262-100%0.262-100%
Operating Ratio--0.7010.740-5%0.757-7%0.735-5%0.735-5%
Pb Ratio27.180+12%23.94123.741+1%17.146+40%15.286+57%15.286+57%
Pe Ratio151.943+12%133.840131.628+2%96.629+39%85.334+57%85.334+57%
Peg Ratio---2138.98412849.270-117%-1733.013-19%4002.543-153%4002.543-153%
Price Per Share120.020+12%105.72097.040+9%61.383+72%66.901+58%66.901+58%
Price To Total Gains Ratio247.479+12%217.992234.211-7%182.642+19%176.531+23%176.531+23%
Profit Growth---12.299-3.841-69%-3.049-75%-4.558-63%-4.558-63%
Quick Ratio--0.4480.445+1%0.388+15%0.412+9%0.412+9%
Return On Assets--0.0610.065-6%0.076-20%0.076-20%0.076-20%
Return On Equity--0.1790.182-2%0.180-1%0.185-3%0.185-3%
Revenue Growth---0.0720.003-2194%-0.028-61%-0.027-63%-0.027-63%
Total Gains Per Share--0.4850.494-2%0.401+21%0.705-31%0.705-31%
Total Gains Per Share Growth---0.535-0.220-59%-0.202-62%-0.675+26%-0.675+26%
Usd Book Value--10523846039.0009818929848.750+7%8726747941.188+21%8584190661.571+23%8584190661.571+23%
Usd Book Value Change Per Share--0.5100.152+235%0.100+411%0.423+21%0.423+21%
Usd Book Value Per Share--4.6484.299+8%3.763+24%3.040+53%3.040+53%
Usd Dividend Per Share---0.368-100%0.322-100%0.319-100%0.319-100%
Usd Eps--0.8310.782+6%0.677+23%0.551+51%0.551+51%
Usd Price Per Share126.321+12%111.270102.135+9%64.605+72%70.414+58%70.414+58%
Usd Profit--1882509288.5001785931388.563+5%1567650492.875+20%1578827298.607+19%1578827298.607+19%
Usd Revenue--5832838698.7505556886697.063+5%4590718983.125+27%4776272131.946+22%4776272131.946+22%
Usd Total Gains Per Share--0.5100.520-2%0.422+21%0.742-31%0.742-31%
 EOD+2 -3MRQTTM+17 -16YOY+18 -165Y+16 -1810Y+16 -18

3.2. Fundamental Score

Let's check the fundamental score of Novo Nordisk A/S based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15151.943
Price to Book Ratio (EOD)Between0-127.180
Net Profit Margin (MRQ)Greater than00.323
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.448
Current Ratio (MRQ)Greater than10.939
Debt to Asset Ratio (MRQ)Less than10.660
Debt to Equity Ratio (MRQ)Less than11.941
Return on Equity (MRQ)Greater than0.150.179
Return on Assets (MRQ)Greater than0.050.061
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Novo Nordisk A/S based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose119.240
Total0/1 (0.0%)



Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in DKK. All numbers in thousands.

Summary
Total Assets218,928,000
Total Liabilities144,476,000
Total Stockholder Equity74,452,000
 As reported
Total Liabilities 144,476,000
Total Stockholder Equity+ 74,452,000
Total Assets = 218,928,000

Assets

Total Assets218,928,000
Total Current Assets102,979,000
Long-term Assets102,979,000
Total Current Assets
Cash And Cash Equivalents 22,758,000
Short-term Investments 8,279,000
Net Receivables 40,826,000
Inventory 21,706,000
Total Current Assets  (as reported)102,979,000
Total Current Assets  (calculated)93,569,000
+/- 9,410,000
Long-term Assets
Long Term Investments 1,242,000
Long-term Assets  (as reported)115,949,000
Long-term Assets  (calculated)1,242,000
+/- 114,707,000

Liabilities & Shareholders' Equity

Total Current Liabilities109,655,000
Long-term Liabilities34,821,000
Total Stockholder Equity74,452,000
Total Current Liabilities
Short Long Term Debt 1,256,000
Accounts payable 14,654,000
Other Current Liabilities 24,014,000
Total Current Liabilities  (as reported)109,655,000
Total Current Liabilities  (calculated)39,924,000
+/- 69,731,000
Long-term Liabilities
Long term Debt 24,178,000
Long-term Liabilities Other 167,000
Long-term Liabilities  (as reported)34,821,000
Long-term Liabilities  (calculated)24,345,000
+/- 10,476,000
Total Stockholder Equity
Retained Earnings 73,166,000
Total Stockholder Equity (as reported)74,452,000
Total Stockholder Equity (calculated)73,166,000
+/- 1,286,000
Other
Capital Stock456,000
Common Stock Shares Outstanding 2,264,344
Net Debt 2,676,000
Net Invested Capital 99,886,000
Net Working Capital -6,676,000



Balance Sheet

Currency in DKK. All numbers in thousands.

 Trend2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
> Total Assets 
110,135,000
117,909,000
124,908,000
125,612,000
126,256,000
136,121,000
139,947,000
144,922,000
141,387,000
158,095,000
174,084,000
194,508,000
197,136,000
218,928,000
218,928,000197,136,000194,508,000174,084,000158,095,000141,387,000144,922,000139,947,000136,121,000126,256,000125,612,000124,908,000117,909,000110,135,000
   > Total Current Assets 
52,734,000
58,720,000
63,400,000
62,456,000
63,193,000
73,579,000
73,667,000
65,809,000
61,389,000
77,146,000
91,213,000
85,595,000
86,537,000
102,979,000
102,979,00086,537,00085,595,00091,213,00077,146,00061,389,00065,809,00073,667,00073,579,00063,193,00062,456,00063,400,00058,720,00052,734,000
       Cash And Cash Equivalents 
9,055,000
14,457,000
18,757,000
15,475,000
9,765,000
24,874,000
25,480,000
12,757,000
5,683,000
24,229,000
29,493,000
10,720,000
13,394,000
22,758,000
22,758,00013,394,00010,720,00029,493,00024,229,0005,683,00012,757,00025,480,00024,874,0009,765,00015,475,00018,757,00014,457,0009,055,000
       Short-term Investments 
0
0
0
0
0
0
0
0
1,983,000
2,987,000
5,897,000
6,765,000
6,752,000
8,279,000
8,279,0006,752,0006,765,0005,897,0002,987,0001,983,00000000000
       Net Receivables 
21,486,000
23,246,000
22,519,000
24,912,000
30,091,000
25,686,000
24,358,000
27,734,000
28,029,000
26,098,000
29,860,000
40,643,000
36,241,000
40,826,000
40,826,00036,241,00040,643,00029,860,00026,098,00028,029,00027,734,00024,358,00025,686,00030,091,00024,912,00022,519,00023,246,00021,486,000
       Inventory 
16,838,000
17,129,000
17,509,000
17,641,000
17,261,000
17,809,000
18,105,000
18,536,000
18,653,000
18,822,000
18,899,000
19,621,000
20,289,000
21,706,000
21,706,00020,289,00019,621,00018,899,00018,822,00018,653,00018,536,00018,105,00017,809,00017,261,00017,641,00017,509,00017,129,00016,838,000
   > Long-term Assets 
57,401,000
59,189,000
61,508,000
63,156,000
63,063,000
62,542,000
66,280,000
79,113,000
79,998,000
80,949,000
82,871,000
108,913,000
110,599,000
115,949,000
115,949,000110,599,000108,913,00082,871,00080,949,00079,998,00079,113,00066,280,00062,542,00063,063,00063,156,00061,508,00059,189,00057,401,000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
4,346,000
0
0
004,346,00000000000000
       Long Term Investments 
1,706,000
2,098,000
2,062,000
1,808,000
1,725,000
1,850,000
1,633,000
1,648,000
1,749,000
1,839,000
1,778,000
1,441,000
1,279,000
1,242,000
1,242,0001,279,0001,441,0001,778,0001,839,0001,749,0001,648,0001,633,0001,850,0001,725,0001,808,0002,062,0002,098,0001,706,000
       Intangible Assets 
0
0
0
5,835,000
0
0
0
20,657,000
0
0
0
38,825,000
0
0
0038,825,00000020,657,0000005,835,000000
       Long-term Assets Other 
57,401,000
59,189,000
61,508,000
63,156,000
63,063,000
0
0
0
0
0
0
0
0
0
00000000063,063,00063,156,00061,508,00059,189,00057,401,000
> Total Liabilities 
62,816,000
64,824,000
71,955,000
68,019,000
71,857,000
76,067,000
80,374,000
81,597,000
82,891,000
92,536,000
107,972,000
123,762,000
130,586,000
144,476,000
144,476,000130,586,000123,762,000107,972,00092,536,00082,891,00081,597,00080,374,00076,067,00071,857,00068,019,00071,955,00064,824,00062,816,000
   > Total Current Liabilities 
54,760,000
56,595,000
63,087,000
58,983,000
63,187,000
67,284,000
70,948,000
70,273,000
72,384,000
72,798,000
88,328,000
99,516,000
95,602,000
109,655,000
109,655,00095,602,00099,516,00088,328,00072,798,00072,384,00070,273,00070,948,00067,284,00063,187,00058,983,00063,087,00056,595,00054,760,000
       Short-term Debt 
1,114,000
1,255,000
1,416,000
659,000
0
0
0
0
0
0
0
0
0
0
0000000000659,0001,416,0001,255,0001,114,000
       Short Long Term Debt 
1,114,000
1,255,000
1,416,000
659,000
1,244,000
1,408,000
1,468,000
6,684,000
6,823,000
1,301,000
1,350,000
12,862,000
1,396,000
1,256,000
1,256,0001,396,00012,862,0001,350,0001,301,0006,823,0006,684,0001,468,0001,408,0001,244,000659,0001,416,0001,255,0001,114,000
       Accounts payable 
4,222,000
5,269,000
5,894,000
6,358,000
5,344,000
8,961,000
6,123,000
5,717,000
6,800,000
7,616,000
8,877,000
8,870,000
6,679,000
14,654,000
14,654,0006,679,0008,870,0008,877,0007,616,0006,800,0005,717,0006,123,0008,961,0005,344,0006,358,0005,894,0005,269,0004,222,000
       Other Current Liabilities 
16,993,000
14,746,000
16,232,000
15,819,000
16,454,000
13,991,000
16,300,000
18,370,000
17,343,000
14,591,000
19,239,000
21,784,000
24,117,000
24,014,000
24,014,00024,117,00021,784,00019,239,00014,591,00017,343,00018,370,00016,300,00013,991,00016,454,00015,819,00016,232,00014,746,00016,993,000
   > Long-term Liabilities 
8,056,000
8,229,000
8,868,000
9,036,000
8,670,000
8,783,000
9,426,000
11,324,000
10,507,000
19,738,000
19,644,000
24,246,000
34,984,000
34,821,000
34,821,00034,984,00024,246,00019,644,00019,738,00010,507,00011,324,0009,426,0008,783,0008,670,0009,036,0008,868,0008,229,0008,056,000
       Long term Debt 
3,204,000
2,977,000
2,927,000
0
2,866,000
2,735,000
2,636,000
0
2,832,000
12,463,000
12,398,000
9,654,000
24,084,000
24,178,000
24,178,00024,084,0009,654,00012,398,00012,463,0002,832,00002,636,0002,735,0002,866,00002,927,0002,977,0003,204,000
       Capital Lease Obligations 
0
0
0
3,824,000
0
0
0
3,672,000
0
0
0
4,129,000
0
0
004,129,0000003,672,0000003,824,000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
360,000
257,000
167,000
167,000257,000360,00000000000000
> Total Stockholder Equity
47,319,000
53,085,000
52,953,000
57,593,000
54,399,000
60,054,000
59,573,000
63,325,000
58,496,000
65,559,000
66,112,000
70,746,000
66,550,000
74,452,000
74,452,00066,550,00070,746,00066,112,00065,559,00058,496,00063,325,00059,573,00060,054,00054,399,00057,593,00052,953,00053,085,00047,319,000
   Common Stock00000000000000
   Retained Earnings 
48,584,000
53,558,000
53,721,000
57,817,000
54,854,000
60,014,000
59,850,000
63,774,000
60,297,000
67,179,000
67,914,000
72,004,000
66,612,000
73,166,000
73,166,00066,612,00072,004,00067,914,00067,179,00060,297,00063,774,00059,850,00060,014,00054,854,00057,817,00053,721,00053,558,00048,584,000
   Capital Surplus 00000000000000
   Treasury Stock00000000000000
   Other Stockholders Equity 00000000000000



Balance Sheet

Currency in DKK. All numbers in thousands.




Cash Flow

Currency in DKK. All numbers in thousands.




Income Statement

Currency in DKK. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue140,800,000
Cost of Revenue-23,658,000
Gross Profit117,142,000117,142,000
 
Operating Income (+$)
Gross Profit117,142,000
Operating Expense-82,156,000
Operating Income58,644,00034,986,000
 
Operating Expense (+$)
Research Development17,772,000
Selling General Administrative41,058,000
Selling And Marketing Expenses-
Operating Expense82,156,00058,830,000
 
Net Interest Income (+$)
Interest Income231,000
Interest Expense-289,000
Net Interest Income-180,000-58,000
 
Pretax Income (+$)
Operating Income58,644,000
Net Interest Income-180,000
Other Non-Operating Income Expenses-
Income Before Tax (EBT)59,080,00058,028,000
EBIT - interestExpense = -289,000
47,757,000
48,046,000
Interest Expense289,000
Earnings Before Interest and Taxes (ebit)-59,369,000
Earnings Before Interest and Taxes (ebitda)65,394,000
 
After tax Income (+$)
Income Before Tax59,080,000
Tax Provision-11,323,000
Net Income From Continuing Ops47,757,00047,757,000
Net Income47,757,000
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net616,000180,000
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
AET.LSE
1 minute ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of AET.LSE.

AET.LSE Daily Candlestick Chart
AEX.INDX
1 minute ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of AEX.INDX.

AEX.INDX Daily Candlestick Chart
ACKB.BR
5 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ACKB.BR.

ACKB.BR Daily Candlestick Chart
3SIL.LSE
23 minutes ago

I found you a MACD Bearish Reversal Divergence on the daily chart of 3SIL.LSE.

3SIL.LSE Daily Candlestick Chart
0R40.LSE
1 hour ago

I found you a Death Cross on the daily chart of 0R40.LSE.

0R40.LSE Daily Candlestick Chart
0QGU.LSE
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 0QGU.LSE.

0QGU.LSE Daily Candlestick Chart
0QHL.LSE
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 0QHL.LSE.

0QHL.LSE Daily Candlestick Chart
0QGU.IL
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 0QGU.IL.

0QGU.IL Daily Candlestick Chart
0Q7S.LSE
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 0Q7S.LSE.

0Q7S.LSE Daily Candlestick Chart
0O8F.LSE
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 0O8F.LSE.

0O8F.LSE Daily Candlestick Chart
0NX0.LSE
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 0NX0.LSE.

0NX0.LSE Daily Candlestick Chart
0MPM.LSE
1 hour ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of 0MPM.LSE.

0MPM.LSE Daily Candlestick Chart
0MPJ.LSE
1 hour ago

I found you a Golden Cross on the daily chart of 0MPJ.LSE.

0MPJ.LSE Daily Candlestick Chart
0MLH.IL
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 0MLH.IL.

0MLH.IL Daily Candlestick Chart
0J6X.LSE
1 hour ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of 0J6X.LSE.

0J6X.LSE Daily Candlestick Chart
0IXZ.LSE
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 0IXZ.LSE.

0IXZ.LSE Daily Candlestick Chart
0IT3.IL
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 0IT3.IL.

0IT3.IL Daily Candlestick Chart
0HAH.LSE
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 0HAH.LSE.

0HAH.LSE Daily Candlestick Chart
0H3T.LSE
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 0H3T.LSE.

0H3T.LSE Daily Candlestick Chart
0EEE.LSE
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 0EEE.LSE.

0EEE.LSE Daily Candlestick Chart
0FM1.LSE
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 0FM1.LSE.

0FM1.LSE Daily Candlestick Chart
0DJI.LSE
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 0DJI.LSE.

0DJI.LSE Daily Candlestick Chart
JSCP.NYSE ARC
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of JSCP.NYSE ARC.

JSCP.NYSE ARC Daily Candlestick Chart
JPMB.NYSE ARC
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of JPMB.NYSE ARC.

JPMB.NYSE ARC Daily Candlestick Chart
JPIN.NYSE ARC
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of JPIN.NYSE ARC.

JPIN.NYSE ARC Daily Candlestick Chart